|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12P 21/06 | (2013.01) |
| C12P 21/06 | (2006.01) | ||
| A61K 38/48 | (2006.01) | ||
| C12Y 304/24069 | (2013.01) | ||
| A61K 38/4893 | (2013.01) | ||
| C12N 9/6489 | (2013.01) | ||
| A61P 1/04 | (2018.01) | ||
| A61P 11/04 | (2018.01) | ||
| A61P 13/08 | (2018.01) | ||
| A61P 13/10 | (2018.01) | ||
| A61P 15/02 | (2018.01) | ||
| A61P 17/00 | (2018.01) | ||
| A61P 19/08 | (2018.01) | ||
| A61P 21/00 | (2018.01) | ||
| A61P 21/02 | (2018.01) | ||
| A61P 25/02 | (2018.01) | ||
| A61P 25/06 | (2018.01) | ||
| A61P 25/08 | (2018.01) | ||
| A61P 25/14 | (2018.01) | ||
| A61P 25/16 | (2018.01) | ||
| A61P 27/02 | (2018.01) | ||
| A61P 29/00 | (2018.01) | ||
| A61P 3/04 | (2018.01) | ||
| A61P 31/04 | (2018.01) | ||
| A61P 31/10 | (2018.01) | ||
| A61P 31/12 | (2018.01) | ||
| A61P 33/00 | (2018.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 7/00 | (2018.01) | ||
| A61P 9/10 | (2018.01) | ||
| Y02A 50/30 | (2018.01) |
| (11) | Number of the document | 3591065 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19178079.0 |
| Date of filing the European patent application | 2015-04-29 | |
| (97) | Date of publication of the European application | 2020-01-08 |
| (45) | Date of publication and mention of the grant of the patent | 2024-01-10 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201407525 | 2014-04-29 | GB |
| (72) |
PALAN, Shilpa , GB
LUI, Sai, Man , GB
HACKETT, Gavin, Stephen , GB
|
| (73) |
Ipsen Bioinnovation Limited ,
Unit 9, Ash Road
Wrexham Industrial Estate, Wrexham LL13 9UF,
GB
|
| (54) | MANUFACTURE OF RECOMBINANT CLOSTRIDIUM BOTULINUM NEUROTOXINS |
| MANUFACTURE OF RECOMBINANT CLOSTRIDIUM BOTULINUM NEUROTOXINS |